S&P 500 7,457.69 -1.01% NASDAQ 25,520.24 -1.40% DOW 52,146.42 -0.77% R2K 2,962.22 -0.42% VIX 18.77 +12.19% US 10Y 4.54 -0.61% DXY 100.75 +0.02% GOLD 4,012.70 +0.68% CRUDE 82.49 +4.48% BITCOIN 64,104.60 +0.32%
Next Bullish Trade
Sign in
AZN

AstraZeneca PLC NYQ · AZN

$168.90 -0.39 (-0.23%)
Pullback · -1.77σ Grade C
+ Compare Open in Sniper

Price chart

Timeframe
Range
Fundamentals · free Click ▲ earnings markers (daily) for the day's move

Loading…

Latest bar · AZN

Momentum reads · latest daily bar
Last
$168.90
-0.39 (-0.23%)
Mkt cap
$261.9B
Healthcare
RSI(14)
39.0
neutral
Stochastic %K
13.8
oversold
MFI(14)
29.9
neutral
ADX(14)
20.5
building

Green means room to run, red means stretched — the reads re-read live as you switch the chart's timeframe. MFI(14) is a volume-weighted money-flow read: above 80 = overbought, below 20 = oversold.

Financial overlay · last 12 quarters

The story behind the price: three years of quarterly results laid over the chart, so you can see whether the stock has been following the business — or running ahead of it.

QuarterRevenue Net incomeOp income FCFNet margin Op margin
2026-03-31 $15.3B $3.1B $4.2B $1.8B 20.1% 27.8%
2025-12-31 $15.5B $2.3B $3.0B $1.1B 15.0% 19.2%
2025-09-30 $15.2B $2.5B $3.6B $3.4B 16.7% 23.6%
2025-06-30 $14.5B $2.5B $3.5B $1.5B 16.9% 24.3%
2025-03-31 $13.6B $2.9B $3.7B $2.7B 21.5% 27.0%
2024-12-31 $nanB $nanB $nanB $nanB nan% nan%

Tip: toggle P/E, FCF, ROE, Gross margin and more on the chart above — every overlay is free.

Compare AZN vs peers

Line AZN up against up to 4 peers (5 tickers total) across ~30 metrics and get one weighted 0-100 verdict — best in green, worst in red. Peers also overlay on the chart above as rebased % lines, or flip the chart to the 2×2 grid for side-by-side mini charts.

Comparing AZN AVGO× MSFT×
Sector peers + LLY + UNH + JNJ + MRK + ABBV + PFE
Popular + AAPL + NVDA + AMZN + GOOG + META + TSLA
Matchups NVDA · AMD · AVGO · SMCI · MU AAPL · MSFT · GOOG · META · AMZN JPM · GS · MS · BAC · C TSLA · RIVN · LCID · GM · F XOM · CVX · OXY · COP
Verdict
Weighted score 0-100 across 3 tickers · best in green
#3
AZN
score 33.2
5/5 inputs
Value score of 80 dominates with attractive PE forward of 19.2, but zero growth score tanks overall ranking.
value 80growth 0quality 18momentum 35sentiment 23
#1
AVGO
score 68.7
5/5 inputs
Growth score of 100 powered by exceptional 85.4% EPS growth and 0.42 PEG drives top ranking despite valuation concerns.
value 37growth 100quality 60momentum 78sentiment 66
#2
MSFT
score 53.1
5/5 inputs
Quality score of 77 with strong margins and sentiment score of 100 offset by weak 19 growth score.
value 47growth 19quality 77momentum 50sentiment 100
AZN
AZN
$168.90
-0.23%
Snapshot
Price 168.9
Day % -0.23
1M % -5.49
3M % -15.75
YTD % -7.78
Market cap 261943099392.0
ADV ($) 375460463.93203735
Beta 0.225
OdysseyHQ zone
Current zone Pullback
Dist 21-EMA % -5.17
Dist ATR (σ) -1.77
OdysseyHQ grade C
Confluence 2
Valuation
P/E (ttm) 25.513596
P/E (fwd) 19.24646
P/S 4.3340077
EV/EBITDA 14.383
P/B 5.527375
FCF yield 0.025
PEG 1.33
Growth
Revenue yoy 0.125
EPS yoy 0.053
FCF yoy —
Revenue trend 8Q
Quality
Gross margin 0.81504995
Operating margin 0.27943
Net margin 0.17188999
ROE 0.23482999
ROA 0.08487
Debt / Equity 0.72
Interest cov. 8.68
Technicals
RSI(14) 39.0
MACD signal bear
vs 50-DMA -7.2
vs 200-DMA -8.56
vs 52w high -20.6
HV-30 39.3
Sentiment
Analyst rec 1.6
Target upside 26.64
Insider buy-sell 90d 1
Risk
Short interest 0.1
Days to cover 0.74
Next earnings 2026-07-27
Full AZN dashboard →
AVGO
Broadcom Inc.
$370.83
-0.97%
Snapshot
Price 370.83
Day % -0.97
1M % -1.56
3M % -6.94
YTD % 6.68
Market cap 1764229775360.0
ADV ($) 9716734651.767548
Beta 1.462
OdysseyHQ zone
Current zone Pullback
Dist 21-EMA % -3.79
Dist ATR (σ) -0.84
OdysseyHQ grade —
Confluence 2
Valuation
P/E (ttm) 61.701332
P/E (fwd) 19.098053
P/S 23.37812
EV/EBITDA 42.998
P/B 20.120728
FCF yield 0.0154
PEG 0.42
Growth
Revenue yoy 0.479
EPS yoy 0.854
FCF yoy —
Revenue trend 8Q
Quality
Gross margin 0.76284
Operating margin 0.48988
Net margin 0.38848
ROE 0.37280998
ROA 0.121190004
Debt / Equity 0.74
Interest cov. 8.08
Technicals
RSI(14) 43.8
MACD signal neutral
vs 50-DMA -7.97
vs 200-DMA 1.98
vs 52w high -25.08
HV-30 66.2
Sentiment
Analyst rec 1.3125
Target upside 41.44
Insider buy-sell 90d -43
Risk
Short interest 1.5
Days to cover 1.9
Next earnings 2026-09-03
Full AVGO dashboard →
MSFT
Microsoft Corporation
$393.82
-1.82%
Snapshot
Price 393.82
Day % -1.82
1M % -0.0
3M % -6.29
YTD % -16.73
Market cap 2925466222592.0
ADV ($) 15501831798.361267
Beta 1.13
OdysseyHQ zone
Current zone Neutral
Dist 21-EMA % 1.16
Dist ATR (σ) 0.37
OdysseyHQ grade —
Confluence 0
Valuation
P/E (ttm) 23.469606
P/E (fwd) 20.324642
P/S 9.191689
EV/EBITDA 16.116
P/B 7.0606165
FCF yield 0.0127
PEG 1.21
Growth
Revenue yoy 0.183
EPS yoy 0.234
FCF yoy —
Revenue trend 8Q
Quality
Gross margin 0.68309
Operating margin 0.46326
Net margin 0.39341998
ROE 0.34013999
ROA 0.14814
Debt / Equity 0.3
Interest cov. 52.84
Technicals
RSI(14) 51.9
MACD signal neutral
vs 50-DMA -1.92
vs 200-DMA -10.36
vs 52w high -29.1
HV-30 34.3
Sentiment
Analyst rec 1.31579
Target upside 41.74
Insider buy-sell 90d 20
Risk
Short interest 1.2
Days to cover 1.84
Next earnings 2026-07-29
Full MSFT dashboard →

Earnings replay · last 20 reports

How this stock actually behaves on report day: each past earnings print with the beat-or-miss and the next-day move — a track record for handicapping the next one.

DateEPS actual EPS estSurprise Next-day
2026-04-29 1.29 1.27 +1.4% +1.2%
2025-11-06 1.19 1.13 +4.9% +1.0%
2025-07-29 0.79 0.88 -10.7% +3.5%
2025-04-29 1.25 1.12 +11.6% +0.1%
2025-02-06 1.05 1.04 +0.8% -0.5%
2024-11-12 1.04 1.03 +1.1% +0.1%
2024-07-25 0.99 0.99 -0.4% -0.5%
2024-04-25 1.03 0.95 +8.4% +0.2%
2024-02-08 0.73 0.76 -4.9% -2.0%
2023-11-09 0.87 0.82 +5.3% -1.4%
2023-07-28 1.08 0.97 +10.9% +0.5%
2023-04-27 0.96 0.82 +17.6% -0.8%
2023-02-09 0.69 0.68 +0.9% +2.2%
2022-11-10 0.84 0.75 +11.9% -3.6%
2022-07-29 0.86 1.04 -17.3% -0.9%
2022-04-29 0.95 1.15 -17.6% +0.1%
2022-02-10 0.84 0.99 -15.6% -1.0%
2021-11-12 0.54 0.91 -40.9% +1.7%
2021-07-29 0.45 0.69 -34.4% -0.7%
2021-04-30 0.82 0.96 -15.3% —

Earnings markers are overlaid on the daily price chart above. Click a ▲ marker for that day's move.

Peer comparison · Healthcare

Context check: the same key numbers for the closest Healthcare names side by side, so you can tell whether this stock is the standout or just moving with its group.

Ticker ⇅ Mkt cap ⇅ P/E ⇅ Fwd P/E ⇅ P/S ⇅ EV/EBITDA ⇅ P/B ⇅ Gross M ⇅ Rev gr ⇅ EPS gr ⇅ FCF yld ⇅
AZN ★ $262B 25.5 19.2 4.3 14.4 5.5 81.5% 12.5% 5.3% 2.50%
LLY $1,051B 41.8 26.3 14.6 30.1 33.8 82.8% 55.5% 169.9% 0.87%
UNH $387B 32.1 19.2 0.9 17.7 4.0 19.5% 0.4% 61.5% 5.88%
JNJ $609B 29.3 19.7 6.2 18.4 7.5 68.1% 6.6% -1.0% —
MRK $315B 36.0 13.2 4.8 12.1 6.9 76.7% 4.9% — 4.46%
ABBV $450B 124.8 15.6 7.2 17.2 -67.6 72.0% 12.4% -46.2% 4.63%
PFE $143B 19.1 8.8 2.3 7.6 1.6 74.8% 5.4% -10.1% 8.67%
TMO $198B 29.2 19.5 4.4 21.1 3.8 40.9% 6.2% 11.3% 2.79%

Auto-seeded from sector. Click any ticker to switch.

Ownership

Who holds the stock and what they've been doing lately — big funds on the left, executives' own buys and sells on the right. Insider buying is the rarer, louder signal.

Top institutional holders

Top-10 concentration: 19.07%

HolderShares% out
Investor AB 51,587,810 3.33%
Vanguard Capital Management LLC 45,040,142 2.90%
Capital International Investors 34,393,013 2.22%
FMR, LLC 29,601,724 1.91%
Capital World Investors 28,264,580 1.82%
Legal & General Group PLC 25,849,978 1.67%
Wellington Management Group, LLP 23,751,085 1.53%
Price (T.Rowe) Associates Inc 19,489,220 1.26%
Bank of America Corporation 19,058,327 1.23%
JPMORGAN CHASE & CO 18,590,922 1.20%

Insider activity · 90d

2 buys / 1 sells · ratio 2.0 · Finnhub

  • Sharma Mani BUY 19,265 @ $190.43
  • Sharma Mani BUY 19,263 @ $179.75
  • Sharma Mani SELL 19,262 @ $185.78

Analyst estimates

Finnhub

What Wall Street expects next: the consensus forecasts for the coming quarters. The market usually reacts to results versus these numbers, not the raw results themselves.

Low
$184.0
Mean
$213.89
High
$240.0
Analysts
10
Recommendation distribution · period 2026-07-01
13
16
4
2
Revision trend (2026-04-01 → 2026-07-01): net 27 → 27 0 (net = strong_buy+buy − sell−strong_sell)

SEC filings

The company's own paperwork, straight from the regulator — annual and quarterly reports, big announcements and insider trades. The primary source behind every headline.

FormFiled DescriptionAction
4 2026-07-08 OWNERSHIP DOCUMENT view ·
4 2026-06-16 OWNERSHIP DOCUMENT view ·
4 2026-05-22 OWNERSHIP DOCUMENT view ·
4 2026-05-08 OWNERSHIP DOCUMENT view ·
4 2021-03-16 4 view ·
4 2020-02-07 4 view ·
4 2019-10-09 FORM 4 SUBMISSION view ·

About AZN

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company offers Imjudo, Datroway, Iressa, Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Crestor, Andexxa, Onglyza, Symlin, XIGDUO XR, Atacand, Atacand HCT, Atacand Plus, Farxiga/Forxiga, Plendil, Modip, Splendil, Munobal, Flodil, Tenormin, Tenormine, Prenormine, Atenol, Zestril, Brilinta/Brilique, Komboglyze, Qtern, Wainua, Byetta, Lokelma, Seloken ZOK, Toprol-XL, Betaloc ZOK, XIGDUO, Accolate, Accoleit, Vanticon, Bricanyl Respules, Eklira Genuair/Tudorza/Bretaris, Pulmicort Turbuhaler, Symbicort Turbuhaler, Airsupra, Bricanyl Turbuhaler, Fasenra, Rhinocort, Tezspire, Bevespi Aerosphere, Daliresp/Daxas, Oxis Turbuhaler, Saphnelo, Breztri Aerosphere, Duaklir Genuair, Pulmicort Respules, and Symbicort pMDI. It also provides Beyfortus, Kavigale, Evusheld, Fluenz/FluMist, Synagis, Kanuma, Ultomiris, Koselugo, Voydeya, Soliris, Strensiq, Nexium, and other medicines. The company offers its products for ocology, cardiovascular, renal and metabolism, respiratory & immunology, vaccines and immune, and th…

Options picks · AZN

ITM + OTM ideas from the latest scan

Loading…

Congress trades · AZN

STOCK Act disclosures

Loading…

SEC filings & insiders · AZN

EDGAR · live

Loading…

Holders · AZN

Institutions & insider activity

Loading…